Hematology Times

Welcome to HematologyTimes.com		New Articles
		New drug could prove superior to warfarin [+] Studies elucidate role CEBPA mutations play in AML [+] Solid tumor drug increases risk of VTE [+] Bacteria can directly cause thrombosis [+] Trial pinpoints optimal dose of novel TKI [+] German study promotes use of lyophilized plasma [+] Simplified diagnostic model as effective as original [+] Novel agent more effective than standard therapy in NHL [+]

Solving Platelet Dysfunctions and Deficiencies in the Era of Thrombopoietin-stimulating Agents [+]
Targeting FLT3 for treatment of leukemia
Presented by Donald Small, MD, PhD[+]
Treatment of indolent NHL: The old and the new
Presented by Jonathan W. Friedberg, MD. [+]
The pathophysiology of thrombopoiesis
Presented at Cytopenias 2007 by Amy Geddis, MD, PhD. [+]
Thrombopoietic-like agents
Presented at Cytopenias 2007 by Terry Gernsheimer, MD. [+]
Mechanisms of effect of IVIg and IV anti-D in ITP
Presented at Cytopenias 2007 by Alan Lazarus, PhD. [+]